According to FDA Commissioner Marty Markery, approvals for exceptionally rare diseases should be granted on a ”conditional basis” where a randomized study is not required
发布者:BY MARIA OUTZE NIELSEN,转转请注明出处:https://robotalks.cn/new-fda-commissioner-will-approve-orphan-drugs-for-rare-diseases-on-a-conditional-basis/